ERBB2 and neoplasm: Expression was correlated with larger tumor size (p < 0.001) (like in our study), clinical node metastasis (p = 0.004), higher clinical stage (p < 0.001), higher nuclear grade (p = 0.005), hormone receptor positivity (p < 0.001), and HER2 negativity (p < 0.001) [27].